IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aptevo Therapeutics Inc (APVO)

CUSIP: 03835L702 | NYSE | Healthcare · Biotechnology | Micro Cap | 18 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q4 2016
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/ACVI Investments, Inc.83,8546.3%New 5%+ stakeJun 30, 2026No 13F filer matched
13G/ACVI Investments, Inc.83,854
6.3% of class · Jun 30, 2026

Institutional Holders — Q3 2026

SBI Securities Co., Ltd.105
0.0% of portfolio›$191
Caitong International Asset Management Co., Ltd3
0.0% of portfolio›$5
Danske Bank A/S1
0.0% of portfolio›$2
StyleTurnoverLocationFiled
SBI Securities Co., Ltd.
105$1910.0%GrowthLowTokyo, Mexico2026-10-22
Caitong International Asset Management Co., Ltd
3$50.0%GrowthVery HighHong Kong, South Korea2026-10-29
Danske Bank A/S
1$20.0%GrowthLowCopenhagen V, Greece2026-11-09
New 5%+ stake
No 13F filer matched